Standout Papers
- Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease (2003)
- Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. (2003)
Immediate Impact
1 by Nobel laureates 32 from Science/Nature 68 standout
Citing Papers
RNA phase transitions in repeat expansion disorders
2017 StandoutNature
In vivo aspects of protein folding and quality control
2016 StandoutScience
Works of Eddie Rosa being referenced
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
2003 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eddie Rosa | 1091 | 7 | 214 | 397 | 12 | 1.3k | |
| Lynn Bedford | 1107 | 3 | 234 | 160 | 21 | 1.5k | |
| Yufang Shao | 1192 | 2 | 196 | 225 | 10 | 1.6k | |
| Axel Obermeier | 1152 | 250 | 558 | 19 | 1.7k | ||
| Luisella Toschi | 867 | 3 | 241 | 218 | 25 | 1.3k | |
| Tara J. Dillon | 1186 | 2 | 204 | 380 | 23 | 1.7k | |
| Seema S. Deshpande | 686 | 7 | 197 | 166 | 10 | 1.3k | |
| Stacy L. Donovan | 957 | 8 | 614 | 305 | 18 | 1.5k | |
| Juan Manuel García‐Martínez | 1343 | 2 | 119 | 230 | 18 | 1.6k | |
| Steven Callaghan | 1038 | 5 | 382 | 297 | 14 | 1.6k | |
| Teppei Yamaguchi | 1230 | 26 | 222 | 191 | 15 | 1.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...